Published on: 10th March 2020
Schematic beliefs in psychosis
Dr Christopher Taylor, principal clinical psychologist, has worked on research to characterise core beliefs in psychosis.
This explores core schematic beliefs (strongly-held positive and negative beliefs about the self and others) and their relation to hallucinations and delusions.
Patients with psychosis gave key examples of how early life experiences influenced the development of these beliefs and the relationship with psychotic experiences.
The outcome provides new insights which can help to guide future treatment options. Click here to read more.
Clozapine and schizophrenia
Kathy Morgan, senior pharmacist, has evaluated the effectiveness and acceptability of intramuscular clozapine injection. Clozapine is used as an intervention for treatment-resistant schizophrenia.
Through this study, which included a number of our patients, Kathy and her medical colleagues in Tameside were able to show that intramuscular clozapine can be used safely and effectively; when patients are unable or unwilling to take the oral formulation. Click here to read more.
Medicines management
Petra Brown, chief pharmacist, took part in a study around medicines management.
The study looked at the prevalence, nature and predictors of omitted medication doses in mental health hospitals; and has identified important targets of intervention. Click here to read more.
Games and treatment of mental illness
Gemma Ratcliffe and Martin Fitzgerald, occupational therapists, have had a scoping review published, which looks at how games and gamification can promote treatment and recovery for those with serious mental illness.
The outcome showed a high levels of feasibility, but the potential treatment value is dependent on the games' design, operation, and rationale. Click here to read more.
